These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 10584293)

  • 1. [Recombinant allergens; allergy vaccine in the future?. Interview by Dr. Barbara Scholtissek].
    Valenta R
    Wien Med Wochenschr; 1999; 149(14-15):450-1. PubMed ID: 10584293
    [No Abstract]   [Full Text] [Related]  

  • 2. [Desensitization with allergens: early, specific, effective therapy of immune system almost without side effects. Interview by Dr. Barbara Scholtissek].
    Fiebig H; Kahlert H
    Wien Med Wochenschr; 1999; 149(14-15):447, 449-50. PubMed ID: 10584292
    [No Abstract]   [Full Text] [Related]  

  • 3. Recombinant allergens for immunotherapy.
    Valenta R; Niederberger V
    J Allergy Clin Immunol; 2007 Apr; 119(4):826-30. PubMed ID: 17335886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical trials with recombinant allergens: research studies?
    Pauli G
    Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009; 96():257-64; discussion 264-5. PubMed ID: 20799469
    [No Abstract]   [Full Text] [Related]  

  • 5. [Biological engineering for new asthma therapy].
    Van Hage M; Grönlund H; Gafvelin G
    Lakartidningen; 2008 Jun 25-Jul 1; 105(26-27):1942-5. PubMed ID: 18681377
    [No Abstract]   [Full Text] [Related]  

  • 6. [Interests of recombinant allergens in the practice of allergy].
    Karoui O; Leimgruber A; Spertini F
    Rev Med Suisse; 2013 Jan; 9(368):22-7. PubMed ID: 23367699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allergy diagnosis, allergen repertoires, and their implications for allergen-specific immunotherapy.
    Crameri R
    Immunol Allergy Clin North Am; 2006 May; 26(2):179-89, v. PubMed ID: 16701139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Natural allergens and recombinant allergens].
    Deviller P
    Allerg Immunol (Paris); 1995 Nov; 27(9):316-9. PubMed ID: 8590581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Standardization of allergen-specific immunotherapy vaccines.
    Spangfort MD; Larsen JN
    Immunol Allergy Clin North Am; 2006 May; 26(2):191-206, v-vi. PubMed ID: 16701140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shooting for a faster approach to the immunotherapy target: will cluster become conventional?
    Cox LS
    Ann Allergy Asthma Immunol; 2009 Mar; 102(3):177-8. PubMed ID: 19354062
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of allergy by oral hyposensitization].
    Iorde V; Latsinik G
    Klin Med (Mosk); 1996; 74(4):27-9. PubMed ID: 8999146
    [No Abstract]   [Full Text] [Related]  

  • 12. Allergen vaccines for specific diagnosis.
    Larsen JN; Løwenstein H
    Clin Allergy Immunol; 2000; 15():1-51. PubMed ID: 10943287
    [No Abstract]   [Full Text] [Related]  

  • 13. Allergy Immunotherapy: Are We Making Progress or Just Standing Still?
    Cox LS
    Immunol Allergy Clin North Am; 2020 Feb; 40(1):xiii-xiv. PubMed ID: 31761125
    [No Abstract]   [Full Text] [Related]  

  • 14. Current status of subcutaneous and sublingual immunotherapy with recombinant allergens.
    Jutel M; Solarewicz-Madejek K; Smolinska S
    Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2013; 97():133-9. PubMed ID: 24912327
    [No Abstract]   [Full Text] [Related]  

  • 15. Allergen-specific immunotherapy: current concepts and future directions.
    Bieber T; Simon HU
    Allergy; 2011 Jun; 66(6):709-12. PubMed ID: 21518373
    [No Abstract]   [Full Text] [Related]  

  • 16. [The immunological background of the allergen vaccines application].
    Rogala B
    Wiad Lek; 1999; 52(11-12):539-46. PubMed ID: 10745688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treating allergy: where to from here?
    O'Hehir RE
    Intern Med J; 2009 Aug; 39(8):491-4. PubMed ID: 19732196
    [No Abstract]   [Full Text] [Related]  

  • 18. Peptide and recombinant immunotherapy.
    Larché M
    Immunol Allergy Clin North Am; 2011 May; 31(2):377-89, xi. PubMed ID: 21530826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Future of allergen-specific immunotherapy: better understanding of the mechanisms, novel treatments, and long-term cure.
    Akdis CA
    Immunol Allergy Clin North Am; 2006 May; 26(2):xiii-xxii. PubMed ID: 16701138
    [No Abstract]   [Full Text] [Related]  

  • 20. New routes and formulations for allergen-specific immunotherapy.
    Wheeler AW; Drachenberg KJ
    Allergy; 1997 Jun; 52(6):602-12. PubMed ID: 9226053
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.